Showing results (461-470 of 1,241) with videos related to

Sort By:
Pageof 125
Jac-Antimicrobial Resistance|May 30, 2023
Antimicrobial stewardship in veterinary medicine: a review of online resourcesFergus Allerton, James Russell
Jac-Antimicrobial Resistance|June 1, 2026
Mapping antibiotic treatment failure definitions and criteria in ambulatory care: a systematic literature reviewFade Alkhlaileh, Annelien Dankaerts, Tareq Haddad, et al.
Jac-Antimicrobial Resistance|May 29, 2026
Candidozyma auris susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agentsKatherine S Klamer, Ashish Bhargava, Leonard Johnson, et al.
Jac-Antimicrobial Resistance|June 5, 2026
In vitro activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in JapanKatsunori Yanagihara, Kazuhiro Tateda, Yohei Doi, et al.
Jac-Antimicrobial Resistance|May 4, 2026
Interventions to address antimicrobial resistance in migrants: a systematic reviewLucy Lammie, Amelia Williams-Walker, Laura B Nellums, et al.
Jac-Antimicrobial Resistance|April 30, 2026
CoNS blood culture isolates from very preterm infants: antibiotic susceptibility, synergy testing and mecA gene expressionZuzana Huncikova, Martin O Christensen, Runa Wolden, et al.
Jac-Antimicrobial Resistance|April 30, 2026
Implementing a cycle of antimicrobial stewardship in primary care: a qualitative studyEmily A Whitehorne, Emily Cooper, Catherine V Hayes, et al.
Jac-Antimicrobial Resistance|May 7, 2026
In vitro activity of aztreonam-nacubactam and cefepime-nacubactam against a global collection of clinically important Gram-negative Bacilli collected in 2021-2023James A Karlowsky, Mark Estabrook, Eisuke Suzuki, et al.
Jac-Antimicrobial Resistance|May 6, 2026
Characterization of isavuconazole pharmacokinetics and pharmacodynamics in a real-life cohortMonia Guidi, Jade Couchepin, Ilana Reinhold, et al.
Jac-Antimicrobial Resistance|April 10, 2026
Antibacterial prophylaxis and antimicrobial stewardship in the era of innovative therapies for haematological malignancies: transplantation, cellular therapies and new drugsR Dell'Acqua, M H Parrinello, D Clerici, et al.
Pageof 125